Tango Therapeutics has reported an 82% objective response rate with [...]

The FDA is seeking public feedback on plans to tailor [...]

A US observational study of nearly 7,000 adults with HIV-1 [...]

AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

Johnson & Johnson has reported three-year clinical remission data for [...]

Ryvu Therapeutics has reported preclinical results for RVU602, an experimental [...]

NICE has recommended maralixibat for cholestatic pruritus caused by Alagille [...]

Mursla Bio has published peer-reviewed data showing that isolating liver-derived [...]

MimiVax’s SurVaxM cancer vaccine improved overall survival in a Phase [...]

UK biotech Myomaker Bio has developed lab-grown human neuromuscular junctions [...]